Suchergebnisse - "Huang, Xin"

PubPharm (85)

1

Real-world comparative effectiveness of palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer

enthalten in: Future oncology (London, England) | 2024

von Robert, N. | Chen, C. | Kim, S. | +7

2

The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer : a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results

enthalten in: Future oncology (London, England) | 2024

von Rugo, H. | Im, S. | Joy, A. | +11

3

Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Pfeiler, G. | Hlauschek, D. | Mayer, E. | +49

4

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3-ITD

enthalten in: Molecular oncology | 2023

von Qian, Y. | Zhang, X. | Mao, S. | +13

5

Engineered Sensory Nerve Guides Self-Adaptive Bone Healing via NGF-TrkA Signaling Pathway

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2023

von Zhang, Z. | Wang, F. | Huang, X. | +13

6

Systemic juvenile xanthogranuloma has a higher frequency of ALK translocations than BRAFV600E mutations

enthalten in: Journal of the American Academy of Dermatology | 2023

von Xu, J. | Huang, X. | Wen, Y. | +13

7

Cryo-EM structure shows how two IGF1 hormones bind to the human IGF1R receptor

enthalten in: Biochemical and biophysical research communications | 2022

von Wu, C. | Huang, X. | Dong, F. | +5

8

Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer : Post hoc analyses from PALOMA-2 and PALOMA-3

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Rugo, H. | Im, S. | Joy, A. | +11

9

Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia

enthalten in: Nature communications | 2022

von Zhao, X. | Wang, P. | Diedrich, J. | +17

10

Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC : Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Cristofanilli, M. | Rugo, H. | Im, S. | +17

1
2
3
4
5
6
7
8
9
Nächster »
[9]